These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33434594)

  • 1. Long-term use of spironolactone for acne in women: A case series of 403 patients.
    Garg V; Choi JK; James WD; Barbieri JS
    J Am Acad Dermatol; 2021 May; 84(5):1348-1355. PubMed ID: 33434594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance of spironolactone.
    Hughes BR; Cunliffe WJ
    Br J Dermatol; 1988 May; 118(5):687-91. PubMed ID: 2969259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.
    Layton AM; Eady EA; Whitehouse H; Del Rosso JQ; Fedorowicz Z; van Zuuren EJ
    Am J Clin Dermatol; 2017 Apr; 18(2):169-191. PubMed ID: 28155090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone.
    Barbieri JS; Margolis DJ; Mostaghimi A
    JAMA Dermatol; 2021 Mar; 157(3):296-300. PubMed ID: 33502462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring individualized treatment plans for acne.
    Harper JC
    Cutis; 2008 Jan; 81(1 Suppl):23-5. PubMed ID: 18338655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety of spironolactone in acne: results of an 8-year followup study.
    Shaw JC; White LE
    J Cutan Med Surg; 2002; 6(6):541-5. PubMed ID: 12219252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
    Afzali BM; Yaghoobi E; Yaghoobi R; Bagherani N; Dabbagh MA
    J Dermatolog Treat; 2012 Feb; 23(1):21-5. PubMed ID: 20964565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne.
    Barbieri JS; Choi JK; James WD; Margolis DJ
    J Am Acad Dermatol; 2019 Sep; 81(3):848-851. PubMed ID: 30905798
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.
    Barbieri JS; Choi JK; Mitra N; Margolis DJ
    J Drugs Dermatol; 2018 Jun; 17(6):632-638. PubMed ID: 29879250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Lee O; Farquhar C; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Spironolactone for Acne Vulgaris in Adult Females: An Update of the Literature.
    Barker RA; Wilcox C; Layton AM
    Am J Clin Dermatol; 2020 Apr; 21(2):303-305. PubMed ID: 32166709
    [No Abstract]   [Full Text] [Related]  

  • 13. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study.
    Grandhi R; Alikhan A
    Dermatology; 2017; 233(2-3):141-144. PubMed ID: 28472793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
    Fenton C; Wellington K; Moen MD; Robinson DM
    Drugs; 2007; 67(12):1749-65. PubMed ID: 17683173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians.
    Sato K; Matsumoto D; Iizuka F; Aiba-Kojima E; Watanabe-Ono A; Suga H; Inoue K; Gonda K; Yoshimura K
    Aesthetic Plast Surg; 2006; 30(6):689-94. PubMed ID: 17077951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
    Krunic A; Ciurea A; Scheman A
    J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris.
    Turowski CB; James WD
    Adv Dermatol; 2007; 23():155-63. PubMed ID: 18159900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult female acne treated with spironolactone: a retrospective data review of 70 cases.
    Isvy-Joubert A; Nguyen JM; Gaultier A; Saint-Jean M; Le Moigne M; Boisrobert E; Khammari A; Dreno B
    Eur J Dermatol; 2017 Aug; 27(4):393-398. PubMed ID: 28862134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis from spironolactone.
    Corazza M; Strumìa R; Lombardi AR; Virgili A
    Contact Dermatitis; 1996 Dec; 35(6):365-6. PubMed ID: 9118635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.